Gunderson Dettmer has advised BrainChild Bio. BrainChild Bio, a clinical-stage biotechnology company, has announced the closure of a $116 million Series A financing round. The financing…
BrainChild Bio Raises $116 Million in Series A Financing


Gunderson Dettmer has advised BrainChild Bio. BrainChild Bio, a clinical-stage biotechnology company, has announced the closure of a $116 million Series A financing round. The financing…
…